Archives
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-03
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve the apparent aqueous solubility of poorly soluble hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. This guide supports pharmaceutical and biochemical formulation workflows, but it does not establish therapeutic efficacy, universal bioavailability improvement, or suitability as a standalone biological reagent.
Super-Enhancer Control of KLF6 in Adipogenesis
2026-09-03
Nguyen et al. identify a KLF6-proximal super-enhancer as an important regulatory hub during the differentiation of human adipose-derived stem cells. Their experiments connect PPARγ- and p300-associated enhancer activation, enhancer RNA production, KLF6 induction, and HDAC3-mediated repression of DLK1, providing a mechanistic framework for adipogenic gene control.
CTOP for μ-Opioid Receptor Research
2026-09-02
CTOP provides reversible, selective μ-opioid receptor blockade for separating receptor-driven signaling from downstream pain-circuit effects. This guide translates recent mouse findings into practical binding, signaling, and mechanical hypersensitivity workflows with troubleshooting steps for reproducible assay development.
Cyclic di-GMP Antitoxin Controls Biofilm Persistence
2026-09-02
The 2024 eLife study identifies cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during early biofilm development. By linking adhesion-stage signaling with DNA double-strand breaks, genome instability, and persister formation, the work refines current models of biofilm resilience and antibiotic tolerance.
Calpain Inhibitor I, ALLN: Protocol & QC
2026-09-01
Calpain Inhibitor I, ALLN (SKU A2602) provides a DMSO-compatible research tool for modulating calpain I/II and cathepsin B/L activity in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It is for controlled laboratory experiments only, not for diagnostic, therapeutic, or clinical use, and cellular or animal dosing must be optimized empirically.
KN-62 Workflows for CaMKII Research
2026-09-01
Build reproducible CaMKII experiments with KN-62 across calcium signaling, secretion, metabolism, and proliferation models. This workflow emphasizes matched vehicle controls, orthogonal calcium readouts, and practical troubleshooting to separate kinase-dependent effects from general cellular stress.
(S)-(+)-Methoprene Research Workflows
2026-08-31
Use (S)-(+)-Methoprene as a stereochemically defined juvenile hormone analog to connect Met signaling with insect development, reproduction, and endocrine-disruption phenotypes. This practical guide emphasizes stage-matched dosing, miRNA–mRNA readouts, solvent control, and troubleshooting for reproducible arthropod assays.
GDC-0994: Reading ERK Signaling in Context
2026-08-31
GDC-0994 is a selective ERK1/2 inhibitor for dissecting how MAP kinase signaling connects with cancer phenotypes and cholestatic injury. This guide emphasizes causal assay design, model boundaries, and interpretation beyond a simple phospho-ERK readout.
GW 6471: PPARα Antagonist Workflows
2026-08-30
GW 6471 provides a reversible pharmacological way to test whether PPARα drives lipid disruption, hepatotoxicity, or metabolic phenotypes. This guide translates recent zebrafish toxicology findings into practical workflows for cellular metabolism research, lipid homeostasis studies, and PPARα-related disease modeling.
Sumatriptan as an Anti-Inflammatory Agent
2026-08-29
This systematic review reframes sumatriptan, traditionally used for acute migraine and cluster headache, as a candidate modulator of inflammation through 5-HT1B/1D signaling, nitric oxide pathways, cytokine regulation, caspase activity, and CGRP release. Its practical value lies in organizing diverse preclinical evidence while highlighting the need to distinguish mechanistic promise from clinical validation.
SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis
2026-08-28
The reference study identifies SMYD2 as a pharmacologically actionable regulator of cisplatin-induced chronic kidney disease, linking its increased expression with renal fibrosis, epithelial–mesenchymal transition, and inflammation. Using AZ505 and LLY507 in disease-model and tubular-cell experiments, the authors show that SMYD2 inhibition improves renal injury-associated phenotypes and modulates Smad3, STAT3, and Smad7 signaling.
AZD1390: A Stress-Resolved ATM Assay Strategy
2026-08-28
AZD1390 is a potent ATM kinase inhibitor for dissecting how DNA damage signaling, replication stress, and radiation interact. This article develops a practical assay framework that connects G-quadruplex biology with glioblastoma and lung cancer research without overstating unvalidated mechanisms.
Gamma-Linolenic Acid: Assay Workflows
2026-08-27
Gamma-linolenic acid (GLA) supports practical inflammation, lipid-signaling, and cytotoxicity studies when solvent, oxidation, and viability controls are designed together. This guide translates its LTB4-related activity into executable cell-based workflows while clarifying why recent arachidonic acid vaccine findings should guide comparison experiments rather than justify untested claims about GLA.
Corydalis Alkaloids: PK Variability in MASH
2026-08-27
The reference study integrates plasma pharmacokinetics, tissue distribution, cellular transport, and enzyme regulation to explain how MASH alters the disposition of Corydalis saxicola Bunting total alkaloids. Its findings support disease-state-aware dosing research by linking increased exposure and hepatic accumulation to CYP450, Oatp1b2, P-glycoprotein, and PXR-associated changes.
Homoharringtonine: From Ribosome to Translation
2026-08-26
Homoharringtonine connects a defined ribosomal mechanism with opportunities in leukemia research, cancer biology, and SARS-CoV-2 antiviral research. This thought-leadership analysis translates the evidence into practical experimental and strategic guidance while distinguishing research potential from clinical proof.
778 records 7/52 page Previous Next First page 上5页 678910 下5页 Last page